NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 430 filers reported holding NOVAVAX INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,225,705 | +0.3% | 859,904 | +2.9% | 0.02% | -11.1% |
| Q2 2023 | $6,209,251 | +192.7% | 835,700 | +173.0% | 0.02% | +260.0% |
| Q1 2023 | $2,121,273 | +5.8% | 306,100 | +57.0% | 0.01% | -16.7% |
| Q4 2022 | $2,004,600 | -37.2% | 195,000 | +11.2% | 0.01% | -40.0% |
| Q3 2022 | $3,192,000 | +27.1% | 175,400 | +259.2% | 0.01% | +42.9% |
| Q2 2022 | $2,511,000 | -63.5% | 48,828 | -47.7% | 0.01% | -68.2% |
| Q1 2022 | $6,872,000 | +44.7% | 93,300 | +181.0% | 0.02% | +46.7% |
| Q4 2021 | $4,750,000 | -75.3% | 33,200 | -64.2% | 0.02% | -78.3% |
| Q3 2021 | $19,239,000 | +9.2% | 92,800 | +11.8% | 0.07% | 0.0% |
| Q2 2021 | $17,622,000 | +4125.9% | 83,000 | +3508.7% | 0.07% | +3350.0% |
| Q1 2021 | $417,000 | -6.5% | 2,300 | -42.5% | 0.00% | 0.0% |
| Q4 2020 | $446,000 | -78.7% | 4,000 | -79.3% | 0.00% | -83.3% |
| Q3 2020 | $2,091,000 | +563.8% | 19,300 | +410.7% | 0.01% | +500.0% |
| Q2 2020 | $315,000 | – | 3,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |